The involvement of dopamine in the modulation of sleep and waking

Sleep Medicine Reviews

Volumn 11, Issue 2, 2007, Pages 113-133

  Monti, Jaime M ^a   Monti, Daniel ^b  

^a HOSPITAL DE CLÍNICAS   (Uruguay)

^b Mercy Ambulatory Center   (United States)

Author keywords

Burst firing; D1 like receptors; D2 like receptors; Dopamine; REM sleep; Sleep; Slow wave sleep; Substantia nigra pars compacta; Ventral tegmental area; Waking

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BROMOCRIPTINE; CABERGOLINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE TRANSPORTER; GLUTAMIC ACID; LEVODOPA; LISURIDE; NORADRENALIN; OREXIN; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

AROUSAL; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; DORSAL RAPHE NUCLEUS; EFFERENT NERVE; ELECTROENCEPHALOGRAM; FOREBRAIN; HUMAN; HYPOTHALAMUS; KNOCKOUT MOUSE; LOCUS CERULEUS; MOLECULAR CLONING; NONHUMAN; NUCLEUS ACCUMBENS; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; REM SLEEP DEPRIVATION; RESTLESS LEGS SYNDROME; REVIEW; SENSORY NERVE; SLEEP DISORDER; SLEEP WAKING CYCLE; SLOW WAVE SLEEP; SOMNOLENCE; SPATIAL SUMMATION; SUBSTANTIA NIGRA; THALAMUS; VENTRAL TEGMENTUM;

ANIMALS; BRAIN; BRAIN MAPPING; CIRCADIAN RHYTHM; DOPAMINE; EVOKED POTENTIALS; HUMANS; NERVE NET; NEURONS; RECEPTORS, DOPAMINE; SLEEP STAGES; SLEEP, REM; SUBSTANTIA NIGRA; VENTRAL TEGMENTAL AREA; WAKEFULNESS;

EID: 33847279300     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smrv.2006.08.003     Document Type: Review

References (197)

1. Carlsson A., and Lindqvist M. Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20 (1963) 140-144
2. Le Moal M. Mesocorticolimbic dopaminergic neurons: functional and regulatory roles. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology: the fourth generation of progress (1995), Raven Press, New York 283-294
3. Monti J.M. Catecholamines and the sleep-wake cycle. I. EEG and behavioral arousal. Life Sci 30 (1982) 1145-1157
4. Monti J.M. Catecholamines and the sleep-wake cycle. II. REM sleep. Life Sci 32 (1983) 1401-1415
5. Wauquier A., Clincke G.H.C., Van den Broeck W.A.E., et al. Active and permissive roles of dopamine in sleep-wakefulness regulation. In: Wauquier A., Gaillard J.M., Monti J.M., and Radulovacki M. (Eds). Sleep: neurotransmitters and neuromodulators (1985), Raven Press, New York 107-120
6. Jones B.E., Bobillier P., Pin C., et al. The effect of lesions of catecholamine-containing neurons upon monoamine content of the brain and EEG and behavioral waking in the cat. Brain Res 58 (1973) 157-177
7. **The most important references are denoted by an asterisk. Trulson M.E., Preussler D.W., and Howell G.A. Activity of substantia nigra units across the sleep-waking cycle in freely moving cats. Neurosci Lett 26 (1981) 183-188
8. Trulson M.E., and Preussler D.W. Dopamine-containing ventral tegmental area neurons in freely moving cats: Activity across the sleep-waking cycle and response to stress. Exp Neurol 83 (1984) 367-377
9. Weiner N., and Molinoff P.B. Catecholamines. In: Siegel G.J., Agranoff B.W., Albers R.W., and Molinoff P.B. (Eds). Basic Neurochemistry (1994), Raven Press, New York 261-281
10. Giros B., Jaber M., Jones S.R., et al. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 (1996) 606-612
11. Glover V., Sandler M., Owen F., et al. Dopamine is a monoamine oxidase B substrate in man. Nature 265 (1977) 80-81
12. Cooper J.R., Bloom F.E., and Roth R.H. The biochemical basis of neuropharmacology (1996), Oxford University Press, New York
13. *. Moore R.Y., and Bloom F.E. Central catecholamine neuron system: anatomy and physiology of the dopamine systems. In: Cowan W.M., Hall Z.W., and Kandel E.R. (Eds). Annual Review of Neuroscience Vol. 1 (1978), Annual Reviews Inc, Palo Alto 129-169
14. Pasquier D.A., Kemper T.L., Forbes W.B., et al. Dorsal raphe, substantia nigra and locus coeruleus: interconnections with each other and the neostriatum. Brain Res Bull 2 (1977) 323-339
15. Wirtshafter D., Stratford T.R., and Asin K.E. Evidence that serotonergic projections to the substantia nigra in the rat arise in the dorsal, but not the median, raphe nucleus. Neurosci Lett 77 (1987) 261-266
16. van der Kooy D., and Hattori T. Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: a fluorescent retrograde double labelling study in the rat. Brain Res 186 (1980) 1-7
17. Imai H., Steindler D.A., and Kital S.T. The organization of divergent axonal projections from the midbrain raphe nuclei in the rat. J Comp Neurol 243 (1986) 363-380
18. Herve D., Pickel V.M., Joh T.H., et al. Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Res 435 (1987) 71-83
19. Vertes R.P. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J Comp Neurol 313 (1991) 643-668
20. Leger L., Charnay Y., Hof P.R., et al. Anatomical distribution of serotonin-containing neurons and axons in the central nervous system of the cat. J Comp Neurol 433 (2001) 157-182
21. Sakai K., Salvert D., Touret M., et al. Afferent connections of the nucleus raphe dorsalis in the cat as visualized by the horseradish peroxidase technique. Brain Res 137 (1977) 11-35
22. Beckstead R.M., Domesick V.B., and Nauta W.J. Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res 175 (1979) 191-217
23. Decavel C., Lescaudron L., Mons N., et al. First visualization of dopaminergic neurons with a monoclonal antibody to dopamine: a light and electron microscopic study. J Histochem Cytochem 35 (1987) 1245-1251
24. Kalén P., Skagerberg G., and Lindvall O. Projections from the ventral tegmental area and mesencephalic raphe to the dorsal raphe nucleus in the rat. Brain Res 73 (1988) 69-77
25. Peyron C., Luppi P.H., Kitahama K., et al. Origin of the dopaminergic innervation of the rat dorsal raphe nucleus. Neuroreport 6 (1995) 2527-2531
26. Saper C.B., and Loewy A.D. Projections of the pedunculopontine tegmental nucleus in the rat: evidence for additional extrapyramidal circuitry. Brain Res 252 (1982) 367-372
27. Jackson A., and Crossman A.R. Nucleus tegmenti pedunculopontinus. Efferent connections with special reference to the basal ganglia, studied in the rat by anterograde and retrograde transport of horseradish peroxidase. Neuroscience 10 (1983) 725-765
28. Lavoie B., and Parent A. Pedunculopontine nucleus in the squirrel monkey: distribution of cholinergic and monoaminergic neurons in the mesopontine tegmentum with evidence for the presence of glutamate in cholinergic neurons. J Comp Neurol 344 (1994) 190-209
29. Cornwall J., Cooper J.D., and Phillipson O.T. Afferent and efferent connections of the laterodorsal tegmental nucleus in the rat. Brain Res Bull 25 (1990) 271-284
30. Woolf N.J., Harrison J.B., and Buchwald J.S. Cholinergic neurons of the feline pontomesencephalon. II. Ascending anatomical projections. Brain Res 520 (1990) 55-72
31. Oakman S.A., Faris P.L., Kerr P.E., et al. Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area. J Neurosci 15 (1995) 5859-5869
32. Moore R.Y. Catecholamine innervation of the basal forebrain. I. The septal area. J Comp Neurol 177 (1978) 665-684
33. Hokfelt T., Johansson O., Fuxe K., et al. Immunohistochemical studies on the localization and distribution of monoamine neuron systems in the rat brain. II. Tyrosine hydroxylase in the telencephalon. Med Biol 55 (1977) 21-40
34. Kalivas P.W., Jennes L., and Miller J.S. A catecholaminergic projection from the ventral tegmental area to the diagonal band of Broca: modulation by neurotensin. Brain Res 326 (1985) 229-238
35. Jones B.E., and Cuello A.C. Afferents to the basal forebrain cholinergic cell area from pontomesencephalic-catecholamine, serotonin, and acetylcholine-neurons. Neuroscience 31 (1989) 37-61
36. Semba K., Reiner P.B., McGeer E.G., et al. Brainstem afferents to the magnocellular basal forebrain studied by axonal transport, immunohistochemistry, and electrophysiology in the rat. J Comp Neurol 267 (1988) 433-453
37. Zaborszky L., Cullinan B.E., and Braun A. Afferents to basal forebrain cholinergic projection neurons: an update. Adv Exp Med Biol 295 (1991) 43-100
38. Cheung S., Ballew J.R., Moore K.E., et al. Contribution of dopamine neurons in the medial zona incerta to the innervation of the central nucleus of the amygdala, horizontal diagonal band of Broca and hypothalamic paraventricular nucleus. Brain Res 808 (1998) 174-181
39. Zaborszky L., Cullinan B.E., and Luine V.N. Catecholaminergic-cholinergic interaction in the basal forebrain. Prog Brain Res 98 (1993) 31-49
40. Kim R., Nakano K., Jayaraman A., et al. Projections of the globus pallidus and adjacent structures: an autoradiographic study in the monkey. J Comp Neurol 169 (1976) 263-290
41. 10 region and the locus coeruleus as demonstrated by anterograde and retrograde tracing techniques. J Neural Transm 44 (1979) 77-86
42. Ornstein K., Milon H., McRae-Degueurce A., et al. Biochemical and radioautographic evidence for dopaminergic afferents of the locus coeruleus originating in the ventral tegmental area. J Neural Transm 70 (1987) 183-191
43. Maeda T., Kojima Y., Arai R., et al. Monoaminergic interaction in the central nervous system: a morphological analysis in the locus coeruleus of the rat. Comp Biochem Physiol 98 (1991) 193-202
44. Singewald N., Schneider C., Pfitscher A., et al. In vivo release of catecholamines in the locus coeruleus. N-S Arch Pharmacol 350 (1994) 339-345
45. Schwartz J.C., Arrang J.M., Garbarg M., et al. Histaminergic transmission in the mammalian brain. Physiol Rev 71 (1991) 1-51
46. Brown R.E., Stevens D.R., and Haas H.L. The physiology of brain histamine. Progr Neurobiol 63 (2001) 637-672
47. Panula P., Pirvola U., Auvinen S., et al. Histamine-immunoreactive nerve fibers in the rat brain. Neuroscience 28 (1989) 585-610
48. Ericson H., Watanabe T., and Kohler C. Morphological analysis of the tuberomammillary nucleus in the rat brain: delineation of subgroups with antibody against l-histidine decarboxylase as a marker. J Comp Neurol 1 (1987) 1-24
49. Nambu T., Sakurai T., Mizukami K., et al. Distribution of orexin neurons in the adult rat brain. Brain Res 827 (1999) 243-260
50. Marcus J.N., Aschkenasi C.J., and Lee C.E. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435 (2001) 6-25
51. Freeman A., Ciliax B., Bakay R., et al. Nigrostriatal collaterals to thalamus degenerate in parkinsonian animal models. Ann Neurol 50 (2001) 321-329
52. Deurveilher S., and Semba K. Indirect projections from the suprachiasmatic nucleus to major arousal-promoting cell groups in rat: implications for the circadian control of behavioral state. Neuroscience 130 (2005) 165-183
53. Isobe Y., and Nishino H. Circadian rhythm of drinking and running-wheel activity in rats with 6-hydroxydopamine lesions of the ventral tegmental area. Brain Res 899 (2001) 187-192
54. *. Oades R.D., and Halliday G.M. Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res 434 (1987) 117-165
55. Mansour A., and Watson S.J. Dopamine receptor expression in the Central Nervous System. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology: the fourth generation of progress (1995), Raven Press, New York 207-219
56. Meador-Woodruff J.H. Neuroanatomy of dopamine receptor gene expression: potential substrates for neuropsychiatric illness. Clin Neuropharmacol 18 Suppl 1 (1995) S14-S24
57. Lachowicz J.E., and Sibley D.R. Molecular characteristics of mammalian dopamine receptors. Pharmacol Toxicol 81 (1997) 105-113
58. 2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci USA 88 (1991) 1859-1863
59. Jensen A.A., Pedersen U.B., Din N., et al. Recent advances in brain dopaminergic systems. Biochem Soc Transact 24 (1996) 163-169
60. Neve K.A., Henningsen R.A., Bunzow J.R., et al. Functional characterization of a rat dopamine D-2 receptor cDNA expressed in a mammalian cell line. Mol Pharmacol 36 (1989) 446-451
61. 1 cells. J Biol Chem 265 (1990) 10320-10326
62. *. Missale C., Nash S.R., Robinson S.W., et al. Dopamine receptors: from structure to function. Physiol Rev 78 (1998) 189-225
63. Giros B., Sokoloff P., Martres M.P., et al. Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature 342 (1989) 923-926
64. Usiello A., Baik J.H., Rouge-Pont F., et al. Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408 (2000) 199-203
65. Sibley D.R., and Monsma F.J. Molecular biology of dopamine receptors. Trends Pharmacol Sci 13 (1992) 61-69
66. Emilien G., Maloteaux J.-M., Geurts M., et al. Dopamine receptors-physiological understanding to therapeutic intervention potential. Pharmacol Therap 84 (1999) 133-156
67. *. Grace A.A., and Bunney B.S. The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4 (1984) 2877-2890
68. Grace A.A., and Bunney B.S. Low doses of apomorphine elicit two opposing influences on dopamine cell electrophysiology. Brain Res 333 (1985) 285-298
69. Hyland B.I., Reynolds J.N.J., Hay J., et al. Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience 114 (2002) 475-492
70. 2 receptors to mesostriatal regions of human forebrain. Proc Natl Acad Sci USA 91 (1994) 11271-11275
71. Johnson S.W., and Wu Y.-N. Multiple mechanisms underlie burst firing in rat midbrain dopamine neurons in vitro. Brain Res 1019 (2004) 293-296
72. *. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41 (1991) 1-24
73. Grace A.A. Dopamine. In: Davis K.L., Charney D., Coyle J.T., and Nemeroff C. (Eds). Neuropsychopharmacology-the fifth generation of progress (2002), Lippincott Williams & Wilkins, Philadelphia 119-132
74. Gonon F.G. Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 24 (1988) 19-28
75. Garris P.A., Ciolkowski E.L., Pastore P., et al. Efflux of dopamine from synaptic cleft in the nucleus accumbens of the rat brain. J Neurosci 14 (1994) 6084-6093
76. Chergui H., Akaoka P.J., Charlety C.F., et al. Subthalamic nucleus modulates burst firing of nigral dopamine neurones via NMDA receptors. NeuroReport 5 (1994) 1185-1188
77. Le Moal M., and Simon H. Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol Rev 71 (1991) 155-234
78. Schultz W. Predictive reward signal of dopamine neurons. J Neurophysiol 80 (1998) 1-27
79. *. Rye D.B., and Jankovic J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 58 (2002) 341-346
80. *. Overton P.G., and Clark D. Burst firing in midbrain dopaminergic neurons. Brain Res Rev 25 (1997) 312-334
81. Lokwan S.J., Overton P.G., Berry M.S., et al. Stimulation of the pedunculopontine tegmental nucleus in the rat produces burst firing in A9 dopaminergic neurons. Neuroscience 92 (1999) 245-254
82. Fadel J., and Deutch A.Y. Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 111 (2002) 379-387
83. Kitai S.T., Shepart P.D., Callaway J.C., et al. Afferent modulation of dopamine firing patterns. Curr Opin Neurobiol 9 (1999) 690-697
84. White F.J. Synaptic modulation of mesocorticolimbic dopamine neurons. Annu Rev Neurosci 19 (1996) 405-436
85. Jones B.E. Arousal systems. Front Biosci 8 (2003) S438-S451
86. Clements J.R., and Grant S. Glutamate-like immunoreactivity in neurons of the laterodorsal tegmental and pedunculopontine nuclei in the rat. Neurosci Lett 120 (1990) 70-73
87. Smith I.D., and Grace A.A. Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity. Synapse 12 (1992) 287-303
88. Carr D.B., and Sesack S.R. GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex. Synapse 38 (2000) 114-123
89. Fuster J.M. Frontal lobes. Curr Opin Neurobiol 3 (1993) 160-165
90. Gariano R.F., and Groves P.M. Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices. Brain Res 462 (1988) 194-198
91. Tong Z.Y., Overton P.G., and Clark D. Antagonism of NMDA receptors but not AMPA/kainate receptors block bursting in dopaminergic neurons induced by electrical stimulation of the prefrontal cortex. J Neural Transm 103 (1996) 889-904
92. Paquet M., Tremblay M., Soghomonian J.J., et al. AMPA and NMDA glutamate receptor subunits in midbrain dopaminergic neurons in the squirrel monkey: an immunohistochemical and in situ hybridization study. J Neurosci 17 (1997) 1377-1396
93. Johnson S.W., Seutin V., and North R.A. Burst firing in dopamine neurons induced by N-methyl-d-aspartate: role of electrogenic sodium pump. Science 258 (1992) 665-667
94. Chergui K., Charlety P.J., Akaoka H., et al. Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. Eur J Neurosci 5 (1993) 137-144
95. Wang T., and French E.D. l-glutamate excitation of A10 dopamine neurons is preferentially mediated by activation of NMDA receptors: extra- and intracellular electrophysiological studies in brain slices. Brain Res 627 (1993) 299-306
96. Svensson T.H., and Tung C.S. Local cooling of pre-frontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo. Acta Physiol Scand 136 (1989) 135-136
97. Kretschmer B.D. Modulation of the mesolimbic dopamine system by glutamate: role of NMDA receptors. J Neurochem 73 (1999) 839-848
98. Overton P.G., and Greenfield S.A. Determinants of neuronal firing pattern in the guinea-pig subthalamic nucleus: an in vivo and in vitro comparison. J Neural Transm Park Dis Dement Sect 10 (1995) 41-54
99. Floresco S.B., Seamans J.K., and Phillips A.G. A selective role for dopamine in the nucleus accumbens of the rat in random foraging but not delayed spatial win-shift-based foraging. Behav Brain Res 80 (1996) 161-168
100. Rohrbacher J., Ichinohe N., and Kitai S.T. Electrophysiological characteristics of substantia nigra neurons in organotypic cultures: spontaneous and evoked activities. Neuroscience 97 (2000) 703-714
101. Charara A., Smith Y., and Parent A. Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: Phaseolus vulgaris-leucoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry. J Comp Neurol 364 (1996) 254-266
102. Woolf N.J. Cholinergic systems in mammalian brain and spinal cord. Prog Neurobiol 37 (1991) 475-524
103. Forster G.L., and Blaha C.D. Laterodorsal tegmental stimulation elicits dopamine efflux in the rat nucleus accumbens by activation of acetylcholine and glutamate receptors in the ventral tegmental area. Eur J Neurosci 12 (2000) 3596-3604
104. Scarnati E., Proia A., Campana E., et al. A microiontophoretic study on the nature of the putative synaptic neurotransmitter involved in the pedunculopontine-substantia nigra pars compacta excitatory pathway of the rat. Exp Brain Res 62 (1986) 470-478
105. Grenhoff J., Aston-Jones G., and Svensson T.H. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand 128 (1986) 351-358
106. Gronier B., and Rasmussen K. Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat. Br J Pharmacol 124 (1998) 455-464
107. Lacey M.G., Calabresi P., and North R.A. Muscarine depolarizes rat substantia nigra zona compacta and ventral tegmental neurons in vitro through M1-like receptors. J Pharmacol Exp Ther 253 (1990) 395-400
108. Gronier B., Perry K.W., and Rasmussen K. Activation of the mesocorticolimbic dopaminergic system by stimulation of muscarinic cholinergic receptors in the ventral tegmental area. Psychopharmacology 147 (2000) 347-355
109. Blaha C.D., and Winn P. Modulation of dopamine efflux in the striatum following cholinergic stimulation of the substantia nigra in intact and pedunculopontine tegmental nucleus-lesioned rats. J Neurosci 13 (1993) 1035-1044
110. Pazos A., and Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. Brain Res 346 (1985) 205-230
111. 2 receptor subtypes mRNAs in rat brain. J Comp Neurol 351 (1995) 357-373
112. 1B binding sites in rat brain. N-S Arch Pharmacol 347 (1993) 569-582
113. 1A receptors to dopaminergic neurons within the parabrachial subdivision of the central tegmental area in rat brain. J Comp Neurol 344 (2001) 390-400
114. 10 cell group. Neuroscience 111 (2002) 163-176
115. Cameron D.L., Wessendorf M.W., and Williams J.T. A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids. Neuroscience 77 (1997) 155-166
116. Pessia M., Jiang Z.G., North R.A., et al. Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res 654 (1994) 324-330
117. Gervais J., and Rouillard C. Dorsal raphe stimulation differentially modulates dopaminergic neurons in the ventral tegmental area and substantia nigra. Synapse 35 (2000) 281-291
118. 1A receptor ligands, (R)-8-OHDPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons. N-S Arch Pharmacol 347 (1993) 351-362
119. Prisco S., Pagannone S., and Esposito E. Serotonin-dopamine interaction in the rat ventral tegmental area: and electrophysiological study in vivo. J Pharmacol Exp Ther 271 (1994) 83-90
120. Lejeune F., and Millan M.J. Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535. Synapse 30 (1998) 172-180
121. 1A agonist ±8-OH-DPAT modulates basal and stress-induced changes in medial prefrontal cortical dopamine. Synapse 18 (1994) 218-224
122. Sakaue M., Somboonthum P., Nishihara B., et al. Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex. Br J Pharmacol 129 (2000) 1028-1034
123. 1B receptor is localized predominantly on axon terminals. Neuroscience 58 (1994) 167-182
124. 1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience 88 (1999) 899-915
125. 1B receptors within the ventral tegmental area in regulation of mesolimbic dopaminergic neuronal activity via GABA mechanisms: a study with dual-probe microdialysis. Brain Res 1021 (2004) 82-91
126. Di Giovanni G., Di Matteo V., Di Mascio M., et al. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin (2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study. Synapse 35 (2000) 53-61
127. Di Matteo V., Di Giovanni G., Di Mascio M., et al. Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors. Brain Res 865 (2000) 85-90
128. Gobert A., Rivet J.M., Lejeune F., et al. Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 36 (2000) 205-221
129. Campbell A.D., Kohl R.R., and McBride W.J. Serotonin-3 receptor and ethanol-stimulated somatodendritic dopamine release. Alcohol 13 (1996) 569-574
130. 3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons. Eur J Pharmacol 205 (1991) 113-116
131. Grenhoff J., and Svensson T.H. Clonidine modulates dopamine cell firing in rat ventral tegmental area. Eur J Pharmacol 165 (1989) 11-18
132. Korotkova T.M., Sergeeva O.A., Eriksson K.S., et al. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 23 (2003) 7-11
133. Vittoz N.M., and Berridge C.W. Hypocretin/orexin selectively increases dopamine efflux within the frontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology 31 (2006) 384-395
134. Jones B.E., Bobillier P., and Jouvet M. Effect of destruction of neurons containing catecholamines of the mesencephalon on the sleep-wake cycle in cats. C R Seances Soc Biol Fil 163 (1969) 176-180
135. *. Sealfon S.C., and Olanow C.W. Dopamine receptors: from structure to behavior. Trends Neurosci 23 10 Suppl (2000) S34-S40
136. 1A-deficient mutant mice. Eur J Neurosci 10 (1998) 2426-2432
137. 1A dopamine receptors. Neuroscience 86 (1998) 135-146
138. 2 receptors. Nature 377 (1995) 424-428
139. 2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J Neurosci 18 (1998) 3470-3479
140. 3 receptor knock-out mice. Behav Brain Res 130 (2002) 141-148
141. 2 dopamine receptors. J Pharmacol Exp Ther 285 (1998) 1187-1196
142. 3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci USA 93 (1996) 1945-1949
143. 2 receptors. Neuron 19 (1997) 837-848
144. 3 receptor in the morphine-induced rewarding effect and hyperlocomotion. Neuroscience 23 (2003) 1006-1012
145. 3H)spiperone binding. N-S Arch Pharmacol 358 (1998) 342-350
146. 4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90 (1997) 991-1001
147. 5 receptor null mutant mice. Behav Neurosci 115 (2001) 1129-1144
148. Wisor J.P., Nishino S., Sora I., et al. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 21 (2001) 1787-1794
149. Giros B., Jaber M., Jones S.R., et al. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 (1996) 606-612
150. Spielewoy C., Roubert C., Hamon M., et al. Behavioral disturbances associated with hyperdopaminergia in dopamine-transporter knock-out mice. Behav Pharmacol 11 (2000) 279-290
151. Langston J.W., Forno L.S., Rebert C.S., et al. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res 292 (1984) 390-394
152. Tetrud J.W., and Langston J.W. MPTP-induced parkinsonism as a model for Parkinson′s disease. Acta Neurol Scand 126 Suppl (1989) 35-40
153. Takada M., Li Z.K., and Hattori T. Intracerebral MPTP injections in the rat cause cell loss in the substantia nigra, ventral tegmental area and dorsal raphe. Neurosci Lett 78 (1987) 145-150
154. Kopin I.J. MPTP toxicity: implications for research in Parkinson′s disease. Ann Rev Neurosci 11 (1988) 81-96
155. Pungor K., Papp M., Kékesi K., et al. A novel effect of MPTP: the selective suppresion of paradoxical sleep in cats. Brain Res 525 (1990) 310-314
156. Pungor K., Hajnal A., Kékesi K.A., et al. Paradoxical sleep deprivatory effect of a single low dose of MPTP which did not produce dopaminergic cell loss. Exp Brain Res 95 (1993) 473-476
157. Lelkes Z., Stenberg D., and Porkka-Heiskanen T. Effect of MPTP on sleep in rats. Sleep Res 20A (1991) 154
158. Ongini E., and Caporali M.G. Differential effects of dopamine D-1 and D-2 receptor agonists on EEG activity and behavior in the rat. Neuropharmacology 26 (1987) 355-360
159. Ongini E., Caporali M.G., and Massotti M. Stimulation of dopamine D-1 receptors by SKF 38393 induces EEG desynchronization and behavioral arousal. Life Sci 37 (1985) 2327-2333
160. Bo P., Ongini E., Giorgetti A., et al. Synchronization of the EEG and sedation induced by neuroleptics depend upon blockade of both D-1 and D-2 dopamine receptors. Neuropharmacology 27 (1988) 799-805
161. Coffin V.L., Letranyi M.B., and Chipkin R.E. Acute extrapyramidal syndrome in cebus monkeys: development by dopamine D-2 but not D-1 receptors. J Pharmacol Exp Ther 249 (1989) 769-774
162. 2 receptors and by an activation of putative dopamine autoreceptors. Neuropharmacology 32 (1993) 493-500
163. 1 antagonist SCH 23390 administration in rats. Neuropsychopharmacology 3 (1990) 153-162
164. 1 dopamine receptor antagonist SCH 23390 enhances REM sleep in the rat. Neuropharmacology 29 (1990) 889-893
165. 1 receptor is involved in the regulation of REM sleep in the rat. Eur J Pharmacol 194 (1991) 189-194
166. 1 receptor agonists, A68930 and SKF 38393, induce arousal and suppress REM sleep in the rat. Eur J Pharmacol 235 (1993) 83-87
167. 1 receptor antagonist (NNC-687). J Psychiatr Res 37 (2003) 305-312
168. Jones B.E. From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci 26 (2005) 578-586
169. Bagetta G., Corasaniti M.T., Strongoli M.C., et al. Behavioral and ECoG spectrum power effects after intraventricular microinjection of drugs altering dopaminergic transmission in rats. Neuropharmacology 26 (1987) 1047-1052
170. Ahlenius S., Hillegaart V., and Svensson L. Terminal dopaminergic autoreceptors are of minor importance for the sedation produced by DA receptor agonists in rats. Advanc Biosci 82 (1991) 55-58
171. Kropf W., and Kuschinsky K. Electroencephalographic correlates of the sedative effects of dopamine agonists presumably acting on autoreceptors. Neuropharmacology 30 (1991) 953-960
172. *. Monti J.M., Hawkins M., Jantos H., et al. Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat. Psychopharmacology 95 (1988) 395-400
173. Monti J.M., Jantos H., and Fernández M. Effects of the selective dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat. Eur J Pharmaol 169 (1989) 61-66
174. 2 receptor stimulation. J Pharmacol Exp Ther 307 (2003) 386-394
175. Bagetta G., De Sarro G., Priolo E., et al. Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioral and electrocortical sleep in rats. Br J Pharmacol 95 (1988) 860-866
176. Sebban C., Zhang X.Q., Tesolin-Decros B., et al. Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission. Br J Pharmacol 128 (1999) 1045-1054
177. Ongini E., Bonizzoni E., Ferri N., et al. Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat. J Pharmacol Exp Ther 266 (1993) 726-731
178. Seamans J.K., Gorelova N., Durstewitz D., et al. Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci 21 (2001) 3628-3638
179. Sarter M., Bruno J.P., and Turchi J. Basal forebrain afferent projections modulating cortical acetylcholine, attention, and implications for neuropsychiatric disorders. Ann N Y Acad Sci 877 (1999) 368-382
180. 1A receptor mRNA and immunoreactivity in the rat medial septum/diagonal band of Broca - relationships to GABAergic and cholinergic neurons. J Chem Neuroanat 29 (2005) 93-111
181. 1A receptor agonist flesinoxan given locally or systemically on REM sleep in the rat. Eur J Pharmacol 478 (2003) 121-130
182. Parnavelas J.G. Neurotransmitters in the cerebral cortex. In: Uylings H.B.M., Van Eden C.G., De Bruin J.P.C., Corner M.A., and Feenstra M.G.P. (Eds). Progress in brain research vol. 85 (1990), Elsevier, Amsterdam 13-29
183. Detari L., Rasmusson D.D., and Semba K. The role of basal forebrain neurons in tonic and phasic activation of the cerebral cortex. Prog Neurobiol 58 (1999) 249-277
184. 3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats. Eur Neuropsychopharmacol 8 (1998) 113-120
185. Hauser R.A., Gauger L., Anderson W.M., et al. Pramipexole-induced somnolence and episodes of daytime sleep. Mov Disord 15 (2000) 658-663
186. Chokroverty S. Sleep, breathing, and neurologic disorders. In: Chokroverty S., and Daroff R.B. (Eds). Sleep disorders medicine: basic science (1999), Butterworth, Boston 509-571
187. Schäffer J., and Greulich A. Effects of parkinsonian medication on sleep. J Neurol 247 Suppl 4 (2000) IV24/IV27
188. Rye D.B. Parkinson′s disease and RLS: the dopaminergic bridge. Sleep Med 5 (2004) 317-328
189. Wenzel K., Suppan K., Ivanic G., et al. Sleep attacks in patients taking dopamine agonists: review. BMJ 324 (2002) 1483-1487
190. Frucht S.J., Greene P.E., and Fahn S. Sleep episodes in Parkinson′s disease: a wake-up call. Mov Disord 15 (2000) 601-603
191. Montplaisir J., Nicolas A., Godbout R., et al. Restless legs syndrome and periodic limb movement disorders. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and Practice of Sleep Medicine (2000), WB Saunders, Philadelphia 742-752
192. Skagerberg G., and Lindvall O. Organization of diencephalic dopamine neurons projecting to the spinal cord in the rat. Brain Res 342 (1985) 340-351
193. 11 dopamine cell group in the rat using transmitter-specific fluorescent retrograde tracing. Brain Res 177 (1979) 170-175
194. 2 dopamine receptors. Neuroscience 19 (1986) 125-137
195. 4 receptor in human cerebral cortex and striatum. J Neurochem 66 (1996) 915-917
196. 3 dopamine receptors in rat spinal cord: implications for sensory and motor function. Neurosci Lett 303 (2001) 9-12
197. Civelli O., Bunzow J.R., and Grandy D.K. Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 32 (1993) 281-307